Cynata Therapeutics Limited carries a market capitalization of 973,816.00, placing it among publicly traded companies globally.
| Market Cap | 973,816.00 |
| Enterprise Value | N/A |
Cynata Therapeutics Limited's stock has declined approximately -95% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.17 |
| Average Volume (20 Days) | N/A |